Anfotericina FADA Injection 50mg

About Anfotericina FADA Injection 50mg

Anfotericina FADA Injection Uses

• Treatment of severe, life threatening systemic fungal infections
• Managing invasive candidiasis in critically ill patients
• Treating cryptococcal meningitis, including in immunocompromised patients
• Addressing aspergillosis that has spread beyond the lungs
• Managing visceral leishmaniasis in specific clinical settings

Anfotericina FADA Injection Benefits

• Broad activity against a wide range of dangerous fungal organisms
• Remains effective when other antifungal drugs have failed
• Often life saving in patients with weakened immunity
• Long established track record in serious fungal disease management

What Experts Say

Infectious disease specialists reserve amphotericin B for fungal infections that are severe enough to threaten organs or life itself, not for minor skin or nail fungus that responds to simpler creams. It is typically started only after a fungal infection is confirmed or strongly suspected in a hospitalized patient who is already unwell.

The drug binds to a component of the fungal cell membrane called ergosterol, creating pores that let essential contents leak out and kill the fungus from within. This same binding action can also affect human cell membranes to a lesser degree, which explains why the drug carries meaningful side effects during treatment.

In busy hospital settings, this injection is given slowly under close monitoring, with kidney function and electrolyte levels checked regularly throughout the course of treatment. It is never a medicine a patient administers at home without direct medical supervision, unlike many oral antifungal tablets.

Drug Class

• Polyene antifungal

Anfotericina FADA Injection 50mg formula

• Amphotericin B

Available forms

• Injection

How to use Anfotericina FADA Injection 50mg?

• Administer only as a slow intravenous infusion in a hospital setting
• Monitor kidney function and electrolytes before and during treatment
• Premedicate with fever or allergy reducing drugs if advised
• Watch closely for infusion related reactions during administration
• Adjust the dose based on body weight and kidney response
• Never self administer this injection at home

Drug Interactions

• Other nephrotoxic drugs: Combining with certain antibiotics or cyclosporine raises kidney damage risk.
• Corticosteroids: These can worsen potassium loss when used alongside this injection.
• Digoxin: Low potassium caused by this drug can increase digoxin related heart risks.
• Muscle relaxants: Electrolyte changes can intensify the effect of certain muscle relaxant drugs used during surgery.

Risks and warnings

• Kidney toxicity: This is a well known risk, and kidney function must be monitored closely throughout treatment.
• Infusion reactions: Fever, chills and shaking can occur during or shortly after the infusion.
• Electrolyte imbalance: Low potassium and magnesium levels are common with repeated dosing.
• Not for home use: This is a hospital administered drug and should never be self injected.
• Pregnancy caution: Use only if the benefit clearly outweighs potential risk to the baby.
• Blood cell effects: The drug can occasionally lower blood counts during extended treatment.
• Heart rhythm changes: Rapid infusion can affect heart rhythm and blood pressure.

Anfotericina FADA Injection Side Effects

• Fever
• Chills
• Low blood pressure
• Nausea and vomiting
• Kidney function changes
• Low potassium levels
• Headache
• Muscle or joint pain

Storage Conditions

• Store the vial refrigerated as directed by the manufacturer
• Protect from light and use reconstituted solution promptly
• Discard any unused portion after the recommended time window
• Keep out of reach of children.